Efficacy of quantitative analysis of Epstein-Barr virus-infected peripheral blood lymphocytes by in situ hybridization of EBER1 after living- related liver transplantation: A case report

Transplantation

Volumn 63, Issue 9, 1997, Pages 1363-1366

  Nakazawa, Yuichi ^a   Chisuwa, Hisanao ^a   Ikegami, Toshihiko ^a   Hashikura, Yasuhiko ^a   Matsunami, Hidetoshi ^a   Ichikawa, Tetsuo ^a   Oh Ishi, Tsutomu ^b   Kawasaki, Seiji ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INFECTION RISK; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; VIRUS DETECTION;

ACYCLOVIR; ANTIVIRAL AGENTS; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; INFANT; LIVER TRANSPLANTATION; LYMPHOCYTES; LYMPHOPROLIFERATIVE DISORDERS; RNA, VIRAL; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS; VIRAL LOAD; VIRUS ACTIVATION;

EID: 0030943988     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705150-00029     Document Type: Article

References (16)

1. Hanto DW. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative disease. Annu Rev Med 1995; 46: 381.
2. Miller G. Epstein-Barr virus: virology, pathogenesis and medical aspects. In: Fields BN, ed. Virology, 2nd ed. New York: Raven Press, 1990: 1921.
3. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988; 45: 719.
4. Starzl TE, Porter KA, Iwatsuki S, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984; 1: 587.
5. Rocci G, de Felici A, Ragona G, Heinz A. Quantitative evaluation of Epstein-Barr virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N Engl J Med 1977; 296: 132.
6. Pirsch JD, Stratta RJ, Sollinger, et al. Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation. Am J Med 1989; 86: 241.
7. Hironaka T, Nagasaki M, Morikawa S, Hirai K. Detection of Epstein-Barr virus transcripts in chemically or immunologically-activated cells and in a null cell-line (HLN-STL-C) by in situ hybridization with alkaline phosphatase-linked oligonucleotide probes. J Virol Methods 1993; 44: 141.
8. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133: 173.
9. Trainor KJ, Brisco MJ, Story CJ, Morley AA. Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood 1990; 75: 2220.
10. Berg LC, Copenhaver CM, Morrison VA, et al. B-cell lymphoproliferative disorders in solid-organ transplant patients: detection of Epstein-Barr virus by in situ hybridization. Hum Pathol 1992; 23: 159.
11. Ambinder RF, Mann RB. Epstein-Barr-encoded RNA in situ hybridization: diagnostic application. Hum Pathol 1994; 25: 602.
12. Fischer A, Blanche S, Le Bidois J, et al. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 1991; 324: 1451.
13. Shapiro RS, Chauvenet A, McGuire W, et al. Treatment of B-cell lymphoproliferative disorders with interferon-alpha and intravenous gamma globulin. N Engl J Med 1988; 318: 1334.
14. Frizzera G, Hanto DW, Gaji-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasia and lymphomas in renal transplant recipients. Cancer Res 1981; 41: 4262.
15. Kenagy DN, Schlesinger Y, Weck K, Ritter JH, Gaudreault-Keener MM, Storch GA. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 1995; 60: 547.
16. Rooney CM, Loftin SK, Holladay MS, Brenner MK, Krance RA, Heslop HE. Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematol 1995; 89: 98.